{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-23-055985","form_type":"8-K","ticker":"KZR","cik":"0001645666","company_name":"Kezar Life Sciences, Inc.","filed_at":"2023-10-27T23:59:59+00:00","discovered_at":"2026-05-14T18:03:29.925598+00:00","generated_at":"2026-06-09T07:04:54.833164+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"high","headline":"Kezar Life Sciences enters separation agreement with former CMO Noreen Roth Henig","bullets":["Dr. Henig stepped down as CMO effective Oct 6, 2023; separation agreement signed Oct 23, 2023.","Cash severance: 12 months base salary plus 40% of target bonus, paid over 12 months.","Reimbursement of up to 12 months of COBRA premiums; vested stock option exercise extended to Dec 31, 2024.","Severance contingent on a general release of claims effective Oct 31, 2024."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-23-055985","json":"https://secwatch.observer/filing/0000950170-23-055985.json","markdown":"https://secwatch.observer/filing/0000950170-23-055985.md","text":"https://secwatch.observer/filing/0000950170-23-055985.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1645666/000095017023055985/0000950170-23-055985-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1645666/000095017023055985/kzr-20231023.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-09T07:04:54.833164+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"e134d49b73","claim":"Noreen Roth Henig departed as Chief Medical Officer at Kezar Life Sciences, Inc..","evidence_excerpt":"On September 30, 2023, as previously announced, the board of directors of Kezar Life Sciences, Inc. (the “Company”) and Noreen Roth Henig, M.D., the Company’s former Chief Medical Officer, reached the mutual decision for Dr. Henig to step down as Chief Medical Officer effective October 6, 2023.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1645666/000095017023055985/0000950170-23-055985-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"stepped down"},{"label":"Role","value":"Chief Medical Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}